Thyroid dysfunction and immune checkpoint inhibitor outcomes.

被引：0
|
作者：
von Itzstein, Mitchell S.
Lu, Rong
Ali, Sadia
Xie, Donglu
Cai, Jennifer
Xie, Yang
Gerber, David E.
机构：
[1] UT Southwestern, Dallas, TX USA
[2] UT Southwestern Med Ctr, Dallas, TX USA
[3] Univ Texas Southwestern Med Ctr Dallas, Simmons Canc Ctr, Dallas, TX 75390 USA
[4] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15103
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Association between platelet-to-lymphocyte ratio and immune checkpoint inhibitor-induced thyroid dysfunction
    Wang, Ai
    Huang, Huijie
    Chen, Yangli
    Zhao, Zhi
    Cong, Li
    Li, Man
    ENDOCRINE, 2025,
  • [12] Combinatorial immune checkpoint inhibitor therapy in anaplastic thyroid cancer
    Chakraborty, Sanjukta
    Maniyar, Rachana R.
    Dadafarin, Sina
    Ben Rahoma, Ghada
    Singh, Sarnath
    Moscatello, Augustine
    Geliebter, Jan
    Tiwari, Raj K.
    CANCER RESEARCH, 2019, 79 (13)
  • [13] IMMUNE CHECKPOINT INHIBITOR ESOPHAGITIS: TREATMENT OUTCOMES AND COMPLICATIONS
    Mumtaz, Afeerah
    Townsend, Matthew J.
    Sack, Jordan S.
    Grover, Shilpa
    GASTROENTEROLOGY, 2024, 166 (05) : S720 - S721
  • [14] Fertility outcomes post immune checkpoint inhibitor exposure
    Harrold, Emily C.
    Ogle, Martinique
    O'Brien, Erin
    Wilde, Callahan
    Sinopoli, Jenna
    Weiss, Jill
    Martino, Lauren
    Casson, Anne
    Kang, Hey-Joo
    Postow, Michael
    Cercek, Andrea
    CANCER CELL, 2024, 42 (11) : 1808 - 1810
  • [15] Thyroid dysfunction after immune checkpoint inhibitor treatment in a single-center Chinese cohort: a retrospective study
    Wu, Lingge
    Xu, Yan
    Wang, Xiang
    Cheng, Xinqi
    Zhang, Yuelun
    Wang, Yingyi
    Fan, Xinrong
    Zhao, Haitao
    Liu, He
    Chai, Xiaofeng
    Zhang, Li
    Wang, Mengzhao
    Li, Naishi
    Pan, Hui
    Lian, Xiaolan
    ENDOCRINE, 2023, 81 (01) : 123 - 133
  • [16] Thyroid dysfunction after immune checkpoint inhibitor treatment in a single-center Chinese cohort: a retrospective study
    Lingge Wu
    Yan Xu
    Xiang Wang
    Xinqi Cheng
    Yuelun Zhang
    Yingyi Wang
    Xinrong Fan
    Haitao Zhao
    He Liu
    Xiaofeng Chai
    Li Zhang
    Mengzhao Wang
    Naishi Li
    Hui Pan
    Xiaolan Lian
    Endocrine, 2023, 81 : 123 - 133
  • [17] Endocrine Adverse Events Related To Immune Checkpoint Inhibitor Treatment: Relationship Between Antibodies and Severity of Thyroid Dysfunction
    Gonzalez, Maria Miguelez
    Sanz-Pastor, Alba Galdon
    Gomez, Roberto Anez
    Torrecilla, Noemi Brox
    Moreno, Diego Munoz
    Fernandez, Laura Gonzalez
    Rivas, Alejandra Maricel
    Guerra, Aurelio Lopez
    Alvarez, Rosa
    Arranz, Jose Angel
    Rodas, Ivan Marquez
    Escudero, Vicente
    Sanjurjo, Maria
    Vallejo, Javier Martin
    Martin, Miguel
    Albarran, Olga Gonzalez
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2024, 24 (14) : 1628 - 1639
  • [18] Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients
    Donisi, Clelia
    Pretta, Andrea
    Lai, Eleonora
    Liscia, Nicole
    Cadoni, Andrea
    Persano, Mara
    Mariani, Stefano
    Pinna, Giovanna
    Spanu, Dario
    Saba, Giorgio
    Migliari, Marco
    Dubois, Marco
    Atzori, Francesco
    Dessi, Mariele
    Puzzoni, Marco
    Pusceddu, Valeria
    Ziranu, Pina
    Madeddu, Clelia
    Massa, Elena
    Scartozzi, Mario
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [19] Thyroid Dysfunction in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors (ICIs): Outcomes in a Multiethnic Urban Cohort
    D'Aiello, Angelica
    Lin, Juan
    Gucalp, Rasim
    Tabatabaie, Vafa
    Cheng, Haiying
    Bloomgarden, Noah A.
    Tomer, Yaron
    Halmos, Balazs
    CANCERS, 2021, 13 (06)
  • [20] Thyroid Dysfunction in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors (ICI): Outcomes in a Multiethnic Urban Cohort
    D'Aiello, A.
    Lin, J.
    Gucalp, R.
    Tabatabaie, V.
    Cheng, H.
    Bloomgarden, N.
    Tomer, Y.
    Halmos, B.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S286 - S286
12345